China SXT Pharmaceuticals, Inc. (SXTC) |
| 2.55 0 (-0.39%) 07-13 16:00 |
| Open: | 2.52 |
| High: | 2.55 |
| Low: | 2.48 |
| Volume: | 3,967 |
| Market Cap: | 2(M) |
| PE Ratio: | 0.91 |
| Exchange: | NASDAQ |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 3.42 |
| Resistance 1: | 2.93 |
| Pivot price: | 2.42 |
| Support 1: | 1.99 |
| Support 2: | 1.41 |
| 52w High: | 1047 |
| 52w Low: | 1.25 |
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
| EPS | -9.130 |
| Book Value | 26.160 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.007 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -153.28 |
| Return on Assets (ttm) | -15.8 |
| Return on Equity (ttm) | -27.5 |
Tue, 07 Jul 2026
China SXT (SXTC) registers 157.5M-share resale linked to $31.5M pre-paid facility - Stock Titan
Thu, 02 Jul 2026
China SXT Pharmaceuticals, Inc. announced that it expects to receive $28.56 million in funding - marketscreener.com
Wed, 01 Jul 2026
China SXT (NASDAQ: SXTC) 20-F outlines VIE, dual-class shares and China risk - Stock Titan
Wed, 17 Jun 2026
China SXT Pharmaceuticals Inc (SXTC) Institutional Confidence - TradingKey
Mon, 23 Mar 2026
China SXT Pharmaceuticals, Inc. Announces Share Re-classification - Yahoo Finance
Fri, 30 Jan 2026
This Nano-cap Pharma Stock Crashed 30% Today – What Triggered The Sell-off? - Stocktwits
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |